top of page
News
11 April 2024
​
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer
21 December 2022
​
Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease
28 October 2022
​
Nuevocor to Present Pre-clinical Data on its Gene Therapy Candidate for LMNA Dilated Cardiomyopathy at American Heart Association Scientific Sessions 2022
18 April 2022
Nuevocor Founders to Present at the American Society of Gene and Cell Therapy (ASGCT) 2022 Meeting
18 June 2021
​
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
​
bottom of page